Technology News and Research

RSS

Nottingham scientists use MRI technology to assist in treatment, diagnosis of irritable bowel syndrome

Scientists at The University of Nottingham are leading the world in exploiting MRI technology to assist in the treatment and diagnosis of Irritable Bowel Syndrome (IBS), a condition that causes serious inconvenience and discomfort to sufferers.

10 Jan 2014

Undergraduate students develop innovative, non-X-ray device that evaluates spinal movement

Those have undergone extensive back surgery and need repeated X-rays to monitor their progress may soon have access to a new technology that skips the X-rays and repeated radiation exposure, opting instead for an innovative, noninvasive, non-X-ray device that evaluates spinal movement.

10 Jan 2014

Researchers discover key step to stem bleeding, reduce obstruction in blood flow during clot formation

Red blood cells are the body's true shape shifters, perhaps the most malleable of all cell types, transforming - among many other forms -- into compressed discs capable of going through capillaries with diameters smaller than the blood cell itself.

10 Jan 2014

Discovery opens new therapeutic avenue for chronic skin condition affecting millions

Researchers from the La Jolla Institute for Allergy and Immunology have revealed a critical player in the cellular interactions leading to eczema - a chronic inflammatory skin condition affecting more than 14 million U.S. children and adults.

10 Jan 2014

T2HemoStat detection of novel clot behavior could direct therapeutic choices for stroke, heart attack victims

T2 Biosystems, a company developing direct detection products enabling superior diagnostics, announced that scientists from the University of Pennsylvania and T2 Biosystems have published a paper in Blood describing novel clot structure biology detected while testing T2 Bio's T2HemoStat-.

10 Jan 2014

Longer reads: Hospice drains Medicare; false Obamacare 'horror stories;' growing up without vaccines

Hospice patients are expected to die: The treatment focuses on providing comfort to the terminally ill, not finding a cure. To enroll a patient, two doctors certify a life expectancy of six months or less. But over the past decade, the number of "hospice survivors" in the United States has risen dramatically, in part because hospice companies earn more by recruiting patients who aren't actually dying, a Washington Post investigation has found. Healthier patients are more profitable because they require fewer visits and stay enrolled longer (Peter Whoriskey and Dan Keating, 12/26).

9 Jan 2014

More insurers extend premium payment deadlines

The relaxed timetables reflect efforts by the insurance industry, as well as the Obama administration, to "coax" people towards "cementing" their 2014 coverage, reports Bloomberg News. In addition, a Commonwealth survey finds more people are shopping on the new health insurance marketplaces. News outlets also report developments from Minnesota, California, Oregon, Connecticut, Massachusetts and Michigan.

9 Jan 2014

Biogen Idec, Sangamo BioSciences partner to develop therapeutics for hemoglobinopathies

Biogen Idec and Sangamo BioSciences, Inc. announced today an exclusive worldwide collaboration and license agreement focused on the development of therapeutics for hemoglobinopathies, inherited conditions that result from the abnormal structure or underproduction of hemoglobin.

9 Jan 2014

Nottingham scientists exploit MRI technology to assist in the treatment of IBS

Scientists at The University of Nottingham are leading the world in exploiting MRI technology to assist in the treatment and diagnosis of Irritable Bowel Syndrome, a condition that causes serious inconvenience and discomfort to sufferers.

9 Jan 2014

Illumina signs multi-year licensing agreement with Quest Diagnostics

Illumina, Inc. today announced it has entered into a multi-year licensing agreement with Quest Diagnostics, the world's leading provider of diagnostic information services, related to the use of Illumina's next-generation sequencing technology for clinical laboratory testing.

From Illumina, Inc. 9 Jan 2014

K2M receives FDA clearance to market CAYMAN Minimally Invasive plate system

K2M, Inc., the largest privately held spinal device company in the world focused on developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market CAYMAN Minimally Invasive, the latest addition to the company’s CAYMAN product family of plate systems already featuring CAYMAN Anterior, CAYMAN Buttress and CAYMAN Lateral.

9 Jan 2014

Bio-inspired biodegradable surgical glue repairs defects of heart and blood vessels

Gecko Biomedical, a French medical device company developing 'bio-inspired' biodegradable surgical glues and patches for wound closure, announces that the Company's co-founders have published data demonstrating the potential of its paradigm-shifting technologies for minimally invasive reconstructive heart surgery.

9 Jan 2014

Federal report finds electronic health records push lacks key safeguards

Although the federal government is spending more than $22 billion to encourage hospitals and doctors to adopt electronic health records, it has failed to put safeguards in place to prevent the technology from being used for inflating costs and overbilling, according to a new report by a federal oversight agency (Abelson and Creswell, 1/8).

9 Jan 2014

Study finds nearly 70% of U.S. adults experience digital eye strain on using digital devices

A report released today at the 2014 Consumer Electronics Show by The Vision Council finds that nearly 70 percent of U.S. adults experience digital eye strain while on digital devices – including computers, tablets and smartphones.

9 Jan 2014

UMMS assistant professor recognized with Presidential Early Career Award for Scientists and Engineers

University of Massachusetts Medical School Assistant Professor Thomas G. Fazzio, PhD, was recognized as a rising scientific star by President Obama with a Presidential Early Career Award for Scientists and Engineers.

9 Jan 2014

ILiAD, Inserm and IPL sign worldwide license agreement for Bordetella pertussis vaccine technology

ILiAD Biotechnologies, LLC, the French National Institute of Health and Medical Research subsidiary, Inserm Transfert SA, and Institut Pasteur de Lille today announced the signing of scientific collaboration and worldwide license agreements for live attenuated Bordetella pertussis vaccine technology, including BPZE1, developed by the laboratory of Professor Camille Locht. This license agreement covers patent rights from Institut Pasteur de Lille, Inserm, National University of Singapore and National University of Ireland Maynooth.

9 Jan 2014

Viewpoints: Health law debate on contraceptive coverage; Cuccinelli: No investigators for Medicaid fraud; 50 years after the famed report on smoking

The Little Sisters of the Poor, an organization of Roman Catholic nuns that runs nursing homes around the country, is testing the contraceptive coverage mandate of the Affordable Care Act. Last week, we're sorry to say, the nuns won a temporary reprieve from Supreme Court Justice Sonia Sotomayor. Under the law, most employers are required to provide their employees with health insurance that covers birth control. But the Obama administration agreed to a compromise for nonprofit religious groups that object to contraception, exempting them from paying for such coverage. Instead, insurers agreed to absorb the cost. All the religious organization has to do is fill out a simple form attesting to its situation. Unfortunately, even that was too much for the Little Sisters of the Poor (1/7).

9 Jan 2014

Globus Medical acquires Excelsius Surgical

Globus Medical, Inc., a leading musculoskeletal implant manufacturer, today announced that it has acquired Excelsius Surgical. Excelsius Surgical is developing a next generation surgical robotic positioning platform for spine, brain and therapeutic markets.

9 Jan 2014

Teleflex includes Vidacare vascular products in ARROW Vascular Access family

Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, will be showcasing ARROW Vascular Products along with the newly acquired Vidacare vascular product line at the annual Society of Critical Care Medicine, January 9-13 in San Francisco, California.

9 Jan 2014

Bio-inspired adhesive may help surgeons treat congenital heart defects, other heart problems

When a child is born with a heart defect such as a hole in the heart, the highly invasive therapies are challenging due to an inability to quickly and safely secure devices inside the heart.

9 Jan 2014

Technology News and Research

Nottingham scientists use MRI technology to assist in treatment, diagnosis of irritable bowel syndrome

Undergraduate students develop innovative, non-X-ray device that evaluates spinal movement

Researchers discover key step to stem bleeding, reduce obstruction in blood flow during clot formation

Discovery opens new therapeutic avenue for chronic skin condition affecting millions

T2HemoStat detection of novel clot behavior could direct therapeutic choices for stroke, heart attack victims

Longer reads: Hospice drains Medicare; false Obamacare 'horror stories;' growing up without vaccines

More insurers extend premium payment deadlines

Biogen Idec, Sangamo BioSciences partner to develop therapeutics for hemoglobinopathies

Nottingham scientists exploit MRI technology to assist in the treatment of IBS

Illumina signs multi-year licensing agreement with Quest Diagnostics

K2M receives FDA clearance to market CAYMAN Minimally Invasive plate system

Bio-inspired biodegradable surgical glue repairs defects of heart and blood vessels

Federal report finds electronic health records push lacks key safeguards

Study finds nearly 70% of U.S. adults experience digital eye strain on using digital devices

UMMS assistant professor recognized with Presidential Early Career Award for Scientists and Engineers

ILiAD, Inserm and IPL sign worldwide license agreement for Bordetella pertussis vaccine technology

Viewpoints: Health law debate on contraceptive coverage; Cuccinelli: No investigators for Medicaid fraud; 50 years after the famed report on smoking

Globus Medical acquires Excelsius Surgical

Teleflex includes Vidacare vascular products in ARROW Vascular Access family

Bio-inspired adhesive may help surgeons treat congenital heart defects, other heart problems

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News